Idiopathic Pleuroparenchymal Fibroelastosis

Kameron Tavakolian1, Ndausung Udongwo1, Steven Douedi1

  • 1Department of Medicine, Jersey Shore University Medical Center, Neptune City, NJ, USA.

Insights

Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare lung disease. This case report highlights diagnostic challenges and the lack of effective treatments for IPPFE, emphasizing the need for further research.

Area of Science:

  • Pulmonology
  • Radiology
  • Pathology

Background:

  • Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare idiopathic interstitial pneumonia.
  • It affects the pleura and subpleural lung parenchyma, predominantly in the upper lobes.
  • Diagnosis relies on clinical, radiographic, and histopathological findings.

Observation:

  • An 86-year-old female presented with dyspnea and hypoxia.
  • She had a history of pneumomediastinum and unintentional weight loss.
  • Chest CT confirmed radiographic evidence of IPPFE.

Findings:

  • Standard treatments including antibiotics, diuretics, and steroids were ineffective.
  • The patient's condition deteriorated, and she was transitioned to hospice care.
  • IPPFE has a median survival of 2 years and often overlaps with other interstitial lung diseases.

Implications:

  • IPPFE is challenging to diagnose due to overlapping features with other interstitial lung diseases.
  • There are no established treatment guidelines for IPPFE.
  • Further research and case reporting are crucial for improved diagnosis and management strategies.

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
2.0K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
277
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
309
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
3.3K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
46